Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paraplatin and Taxol in Elderly Ovarian Cancer
NCT00231075Phase 2Completed
- Sponsor
- ARCAGY
- Start
- Jan 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carboplatin and paclitaxel in ovarian cancer, sponsored by ARCAGY. Primary endpoint: Feasibility of the combination Paraplatine + Taxol. Started Jan 2001; status: completed.
02
Drugs
carboplatinpaclitaxel
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00231075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00231075.